Key result
Higher serum resistin is strongly linked to greater CHD severity and AMI versus normal controls.
Why the study?
Is increased serum resistin level associated with the presence and severity of coronary heart disease?
Meta-Analysis (n=2,070)
Is increased serum resistin level associated with the presence and severity of coronary heart disease?
Standardized Mean Difference: 3.62 (95% CI 2.62–4.62)
p-value: p=<0.00001
Increased serum resistin levels are significantly associated with the presence and severity of coronary heart disease, with the highest levels observed in acute myocardial infarction.
Supports resistin as a potential CHD biomarker; extends prior observational data but remains hypothesis-generating.
// Jing-Zhan Zhang 1,2 , Ying Gao 3 , Ying-Ying Zheng 1 , Fen Liu 1 , Yi-Ning Yang 1 , Xiao-Mei Li 1 , Xiang Ma 1 , Yi-Tong Ma 1 and Xiang Xie 1 1 Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China 2 Department of Dermatology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China 3 Department of Cadre Ward, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China Correspondence: Xiang Xie, email: // Keywords : coronary heart disease; serum resistin; meta-analysis Received : November 24, 2016 Accepted : January 24, 2017 Published : February 25, 2017 Abstract To explore the relationship between the serum resistin level and different types of coronary heart diseases (CHD). Literature was retrieved by formal searching of PubMed, Web of Science, Google Scholar, the Cochrane Library, Wanfang Data, China Biological Medicine Database (SinoMed) and China National Knowledge Infrastructure (CNKI) and by hand searching of reference lists of related articles. RevMan5.3 statistical software was utilized for processing and analysis. A total of 22 literatures involving 2070 subjects were included. Meta-analysis showed that the level of serum resistin in the patients with stable angina (SA), unstable angina(UA) or acute myocardial infarction (AMI) were significantly higher than those of normal controls, respectively [SMD(95% CI)were 1.97(1.15, 2.79), 2.54(1.76, 3.31), and 3.62(2.62, 4.62), all P <0.00001]. Serum resistin level in patients with UA or AMI was higher than those in patients with SA, respectively [SMD=0.90, 95CI(0.28,1.52), P =0.005], [SMD=2.28, 95%CI(0.74, 3.82), P =0.004].The level of serum resistin in patients with AMI was also higher than those in patients with UA [SMD=1.22, 95%CI(0.58, 1.85), P =0.0002]. The study demonstrated that increased serum resistin level is significantly associated with the severity of CHD.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2017) conducted a meta-analysis in coronary heart disease (n=2,070). Serum resistin vs. Normal controls was evaluated on Serum resistin level in acute myocardial infarction vs normal controls (SMD 3.62, 95% CI 2.62-4.62, p=<0.00001). Increased serum resistin levels were significantly associated with coronary heart disease severity, with higher levels in acute myocardial infarction than normal controls (SMD 3.62; 95% CI 2.62-4.62).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: